Search

  1. RNA therapy

    Page

    … RNA therapy Find out how RNA therapy works, how it differs from … ProQR is at the forefront of delivering targeted therapies for people with inherited retinal diseases. Our RNA …

    RNA illustration

  2. Navigating an improvement in vision

    Community news

    … pipeline in ophthalmology programs that is built on RNA technology. According to Dr. Peter Adamson, ProQR’s … ProQR’s Annual Magazine 2017 Learn more about how RNA therapy works. Dr. Peter Adamson about RNA as the ultimate …

    Photo of Dr. Peter Adamson

  3. “A new way of designing medicines”

    Community news

    … medicines” The potential of this new technology for RNA therapeutics is immense, says Bart Klein, who was at the … Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology … Biology/Molecular Biology. What is Klein’s connection to RNA therapeutics? “At the end of the 80s, I wrote my master’s …

    A photo of Bart Klein

  4. “Putting knowledge based creativity to work”

    Community news

    … push the organization forward. “I am excited about what RNA technology may have in store for the development and … but also for leading the team that developed drugs or gene therapies for those targets and for testing them in phase 1 … drugs were added to the pharmaceutical armamentarium. RNA therapy represent a new platform for drugs as well as a new …

    Photo of Dr. Ted Dryja

  6. Inherited retinal disease resources

    Page

    … no treatment options. We focus on developing intravitreal RNA therapies that treat the underlying cause of inherited … participation email us directly at hcp@proqr.com . RNA therapy – a fundamentally new approach to IRDs For the vast …

    Ophthalmologist doing eye measurements

  7. RNA technology to benefit patients

    Page

    … RNA technology to benefit patients At ProQR science is … where our scientists discover and test our novel RNA therapies. Our passion lies in discovering the latest RNA … about Sepofarsen (QR-110) Sepofarsen (QR-110) is an RNA therapy that aims to restore vision in Leber congenital …

    Two ProQR scientists working in the lab

  8. Acting in the interest of patients

    Page

    An innovative biotech company developing life changing RNA therapies for inherited retinal diseases. Find out more about our treatments and clinical trials.

    Living with Inherited retinal disease - Maartje de Kok and her family

  9. About ProQR Therapeutics

    Page

    … An innovative biotech company developing life changing RNA therapies for inherited retinal diseases. Find out more about … to develop therapies for people in need. What is RNA therapy? Learn about our mission to help treat rare genetic …

    Female scientist working in ProQR's laboratories